Piergiorgio Donati
Chief Tech/Sci/R&D Officer at AC IMMUNE SA
Net worth: 56 153 $ as of 2024-04-29
Profile
Mr. Piergiorgio Donati is a Chief Technical Operations Officer at AC Immune SA. Mr. Donati was previously employed as a Head-CMC Program Development by Glenmark Pharmaceuticals Inc., USA, a Project Manager-Research & Development by Abiogen Pharma SpA, and a Head-Research & Development by Serono SA. He received his undergraduate degree from Technical Institute of Jiangsu.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AC IMMUNE SA
0.02% | 2024-02-29 | 24,521 ( 0.02% ) | 56 153 $ | 2024-04-29 |
Piergiorgio Donati active positions
| Companies | Position | Start |
|---|---|---|
| AC IMMUNE SA | Chief Tech/Sci/R&D Officer | - |
Former positions of Piergiorgio Donati
| Companies | Position | End |
|---|---|---|
Glenmark Pharmaceuticals Inc., USA
 Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Corporate Officer/Principal | 2017-12-31 |
| AC IMMUNE SA | Corporate Officer/Principal | 2015-08-31 |
Abiogen Pharma SpA
 Abiogen Pharma SpA Miscellaneous Commercial ServicesCommercial Services Abiogen Pharma SpA manufactures and develops pharmaceutical products. The firm offers therapeutic drugs in the anti-inflammatory and painkiller, respiratory, bone metabolism, and dermatology areas. The company was founded by Massimo di Martino in 1997 and is headquartered in Pisa, Italy. | Corporate Officer/Principal | 2011-02-28 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Training of Piergiorgio Donati
| Technical Institute of Jiangsu | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private companies | 3 |
|---|---|
Abiogen Pharma SpA
Abiogen Pharma SpA Miscellaneous Commercial ServicesCommercial Services Abiogen Pharma SpA manufactures and develops pharmaceutical products. The firm offers therapeutic drugs in the anti-inflammatory and painkiller, respiratory, bone metabolism, and dermatology areas. The company was founded by Massimo di Martino in 1997 and is headquartered in Pisa, Italy. | Commercial Services |
Glenmark Pharmaceuticals Inc., USA
Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Piergiorgio Donati
